BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prolo LM, Li A, Owen SF, Parker JJ, Foshay K, Nitta RT, Morgens DW, Bolin S, Wilson CM, Vega L JCM, Luo EJ, Nwagbo G, Waziri A, Li G, Reimer RJ, Bassik MC, Grant GA. Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion. Sci Rep 2019;9:14020. [PMID: 31570734 DOI: 10.1038/s41598-019-50160-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Golforoush PA, Narasimhan P, Chaves-Guerrero PP, Lawrence E, Newton G, Yan R, Harding SE, Perrior T, Chapman KL, Schneider MD. Selective protection of human cardiomyocytes from anthracycline cardiotoxicity by small molecule inhibitors of MAP4K4. Sci Rep 2020;10:12060. [PMID: 32694738 DOI: 10.1038/s41598-020-68907-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Anand SK, Caputo M, Xia Y, Andersson E, Cansby E, Kumari S, Henricsson M, Porosk R, Keuenhof KS, Höög JL, Nair S, Marschall H, Blüher M, Mahlapuu M. Inhibition of MAP4K4 Signaling Initiaties Metabolic Reprogramming to Protect Hepatocytes from Lipotoxic Damage. Journal of Lipid Research 2022. [DOI: 10.1016/j.jlr.2022.100238] [Reference Citation Analysis]
3 Hamar J, Kültz D. An efficient vector-based CRISPR/Cas9 system in an Oreochromis mossambicus cell line using endogenous promoters. Sci Rep 2021;11:7854. [PMID: 33846462 DOI: 10.1038/s41598-021-87068-3] [Reference Citation Analysis]
4 Daisy PS, Shreyas KS, Anitha TS. Will CRISPR-Cas9 Have Cards to Play Against Cancer? An Update on its Applications. Mol Biotechnol 2021;63:93-108. [PMID: 33386579 DOI: 10.1007/s12033-020-00289-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tang M, Rich JN, Chen S. Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier. Adv Mater 2021;33:e2004776. [PMID: 33326131 DOI: 10.1002/adma.202004776] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
6 Garcia-Garcia S, Rodrigo-Faus M, Fonseca N, Manzano S, Győrffy B, Ocaña A, Bragado P, Porras A, Gutierrez-Uzquiza A. HGK promotes metastatic dissemination in prostate cancer. Sci Rep 2021;11:12287. [PMID: 34112843 DOI: 10.1038/s41598-021-91292-2] [Reference Citation Analysis]
7 Schuster A, Klein E, Neirinckx V, Knudsen AM, Fabian C, Hau AC, Dieterle M, Oudin A, Nazarov PV, Golebiewska A, Muller A, Perez-Hernandez D, Rodius S, Dittmar G, Bjerkvig R, Herold-Mende C, Klink B, Kristensen BW, Niclou SP. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nat Commun 2020;11:6366. [PMID: 33311477 DOI: 10.1038/s41467-020-20029-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Codrici E, Popescu ID, Tanase C, Enciu AM. Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment. Int J Mol Sci 2022;23:2509. [PMID: 35269652 DOI: 10.3390/ijms23052509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Williams-Simon PA, Ganesan M, King EG. Learning to collaborate: bringing together behavior and quantitative genomics. J Neurogenet 2020;34:28-35. [PMID: 31920134 DOI: 10.1080/01677063.2019.1710145] [Reference Citation Analysis]
10 Kaynar A, Altay O, Li X, Zhang C, Turkez H, Uhlén M, Shoaie S, Mardinoglu A. Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme. Int J Mol Sci 2021;22:13213. [PMID: 34948010 DOI: 10.3390/ijms222413213] [Reference Citation Analysis]
11 Yeini E, Ofek P, Pozzi S, Albeck N, Ben-Shushan D, Tiram G, Golan S, Kleiner R, Sheinin R, Israeli Dangoor S, Reich-Zeliger S, Grossman R, Ram Z, Brem H, Hyde TM, Magod P, Friedmann-Morvinski D, Madi A, Satchi-Fainaro R. P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression. Nat Commun 2021;12:1912. [PMID: 33771989 DOI: 10.1038/s41467-021-22186-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Dent P, Booth L, Poklepovic A, Martinez J, Hoff DV, Hancock JF. Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signaling. J Cell Physiol 2020;235:7889-99. [PMID: 31912905 DOI: 10.1002/jcp.29443] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
13 Lin K, Shen S, Lu F, Zheng P, Wu S, Liao J, Jiang X, Zeng G, Wei D. CRISPR screening of E3 ubiquitin ligases reveals Ring Finger Protein 185 as a novel tumor suppressor in glioblastoma repressed by promoter hypermethylation and miR-587. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03284-z] [Reference Citation Analysis]
14 Wang L, Shamardani K, Babikir H, Catalan F, Nejo T, Chang S, Phillips JJ, Okada H, Diaz AA. The evolution of alternative splicing in glioblastoma under therapy. Genome Biol 2021;22:48. [PMID: 33499924 DOI: 10.1186/s13059-021-02259-5] [Reference Citation Analysis]
15 Al-Sammarraie N, Ray SK. Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme. Cells 2021;10:2342. [PMID: 34571991 DOI: 10.3390/cells10092342] [Reference Citation Analysis]
16 Singh SK, Kumar S, Viswakarma N, Principe DR, Das S, Sondarva G, Nair RS, Srivastava P, Sinha SC, Grippo PJ, Thatcher GRJ, Rana B, Rana A. MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3. Oncogene 2021;40:6153-65. [PMID: 34511598 DOI: 10.1038/s41388-021-02007-w] [Reference Citation Analysis]